Kisspeptin
A reproductive-axis signaling peptide studied for its role in GnRH release and fertility-related endocrinology.
This compound has a genuine development or study trail, but it is not an approved routine drug.
This profile is grouped by its dominant research and market lane, not by vendor shelf placement.
No major aliases are tracked for this profile yet.
No FDA label signal · 45 trials · 3198 PubMed results
What kisspeptin is
Kisspeptin is a signaling peptide involved in reproductive endocrine regulation, especially upstream effects on GnRH release.
Why it matters
It gives the library a more serious hormone-signaling category beyond growth hormone and weight loss. It is one of the clearer examples of a peptide that matters scientifically even when it is not a mainstream retail-market name.
Regulatory context
Kisspeptin is not an FDA-approved therapy for routine consumer use in the United States. It fits best in the investigational category.
Practical reading note
Hormone-linked peptides deserve extra care because endocrine language can make a product sound more established than it really is.